Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
Last trade$1.49
Day change-$0.13 (-8.02%)
Day range$1.39 – $1.58
Volume18,904
Market cap$58M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for POM.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for POM.
Recent news
Company coverage with links to the original publishers.
Three small Chinese companies have formally withdrawn their Nasdaq IPO applications since April, signaling pressure from underwriters amid a regulatory crackdown on suspicious 'pump and dump' listings. The withdrawals reflect increased hostility toward Chinese listings on Wall Street, driven by U.S. political pressure and stricter regulations, with the CSRC approving only two new U.S. listings in the past five months.
Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Navan, Inc., where the firm alleges that offering documents for the October 2025 IPO contained false and misleading information regarding increased sales and marketing expenses. The lead plaintiff deadline is April 24, 2026. Additional lawsuits involve Lufax Holding Ltd and PomDoctor Ltd.
Rosen Law Firm is reminding investors in PomDoctor Ltd., Navan, Inc., and Lufax Holding Ltd. of upcoming lead plaintiff deadlines in securities class action lawsuits. PomDoctor investors have until April 13, 2026 to join the class action, which alleges the company was subject to fraudulent stock promotion schemes, insider share dumping, and misleading statements about business operations.
A class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ: POM) alleging that company defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, coordinated share dumping by insiders using offshore accounts, and artificial trading activity that inflated stock prices during the class period of October 9, 2025 to December 11, 2025.
Pomerantz Law Firm has filed class action lawsuits against PomDoctor Ltd. for alleged securities fraud involving a 'pump and dump' scheme using social media impersonators. PomDoctor's stock surged from $4.00 to $6.09 before crashing 91% to $0.50 on December 10, 2025. Similar lawsuits have been filed against AMC Entertainment Holdings and NuScale Power Corporation. Investors with losses are urged to contact the firm by the April 6, 2026 deadline to potentially become lead plaintiffs.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Dec 8, 2015
$4.86
Dec 31, 2015
recurring
Sep 8, 2015
$4.86
Sep 30, 2015
recurring
Jun 8, 2015
$4.86
Jun 30, 2015
recurring
Mar 6, 2015
$4.86
Mar 31, 2015
recurring
Dec 8, 2014
$4.86
Dec 31, 2014
recurring
Stock splits
Historical share-structure events and their execution dates.